R&D News | pharmaphorum

News

AC Immune trials Alzheimer’s vaccine

Switzerland's AC Immune biopharma has begun mid-stage trials of a vaccine against Alzheimer’s disease and Abeta-related cognitive decline in Down Syndrome patients.

News

Opdivo and Keytruda approved in new lung cancer uses

The FDA has approved Merck's Keytruda (pembrolizumab) as a combination treatment for metastatic nonsquamous non-small cell lung cancer (NSCLC), after green-lighting Bristol-Myers Squibb’s (BMS)

News

AstraZeneca gets further approval for Tagrisso in Japan

AstraZeneca received approval from the Japanese regulator following a priority review of Tagrisso (osimertinib) as a first-line treatment of patients with positive non-small cell lung cance

News

Novo's oral semaglutide on target in phase 3 trial

Novo Nordisk continues to build a case for its oral semaglutide GLP-1 class diabetes drug, with latest results from a phase 3a trial showing it is more effective than placebo at reducing bl

News

AstraZeneca to present the latest cardiovascular research

AstraZeneca and MedImmune will present new data from its Cardiovascular, Renal and Metabolism (CVRM) portfolio for the treatment of patients with overlapping diseases and multiple risk fact

News

Novo acquires UK biotech Ziylo to develop "smart" insulin

Danish pharma hopes Ziylo's tech will lead to glucose responsive insulin

AC Immune trials Alzheimer’s vaccine

Opdivo and Keytruda approved in new lung cancer uses

AstraZeneca gets further approval for Tagrisso in Japan

Novo's oral semaglutide on target in phase 3 trial

AstraZeneca to present the latest cardiovascular research

Novo acquires UK biotech Ziylo to develop "smart" insulin

Bavarian Nordic has found its new CEO

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks